EXPM:ZSANQ - Post Discussion
Post by
Humanist on Nov 27, 2019 10:23pm
zsan 2mlns shares offering at 1.45 per share
Zosano prices registered direct offering
Zosano Pharma (ZSAN +16.4%) announced issuance and sale of 2,181,034 common stock at $1.45 per share in a registered direct offering.
The company intends to use the net proceeds to fund pre-approval commercialization activities, including submitting its NDA for Qtrypta (M207) for the treatment of migraine, and for general working capital and corporate purposes.
Be the first to comment on this post